Literature DB >> 17611932

Composition and biological activity of different extracts from Schisandra sphenanthera and Schisandra chinensis.

Constance Huyke1, Kathrin Engel, Birgit Simon-Haarhaus, Karl-Werner Quirin, Christoph M Schempp.   

Abstract

Plants of the Schisandraceae family contain a variety of pharmacologically active lignans like schizandrin, deoxyschizandrin, deangeloylgomisin B, gomisin A, gomisin O, gamma-schizandrin and isogomisin O. Here we have compared the composition of different polar and non-polar extracts of Schisandra sphenanthera and Schisandra chinensis. We also have screened the extracts for antiproliferative and anti-inflammatory effects in different cell-based and cell-free assays. Extracts produced with the non-polar solvents CO(2), hexane and CO(2)/5% ethanol had a similar composition. In contrast, polar extraction with ethanol provided a considerably higher yield, but a lower content of volatiles and lignans in comparison to the non-polar extracts. The proliferation of the epidermal cell lines HaCaT and A431 was dose-dependently inhibited by both the Schisandra sphenanthera and Schisandra chinensis extracts, the non-polar extracts being superior to the polar ones. The non-polar Schisandra sphenanthera extract was the most active with a half-maximal inhibitory concentration of 20 microg/mL. In a cell-free enzyme inhibition assay with recombinant cyclooxygenase-2 (COX-2) the non-polar Schisandra sphenanthera extract dose-dependently inhibited COX-2 catalysed prostaglandin (PG) production (IC(50) = 0.2 microg/mL). It also reduced the ultraviolet-B (UVB)-induced PGE (2) production (IC(50) = 4 microg/mL) and COX-2 expression in HaCaT keratinocytes. We conclude that non-polar SChisandra extracts obtained by CO(2) extraction might be useful in the prevention and treatment of hyperproliferative and inflammatory skin diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611932     DOI: 10.1055/s-2007-981559

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  12 in total

1.  Composition and biochemical properties of ale beer enriched with lignans from Schisandra chinensis Baillon (omija) fruits.

Authors:  Yang Deng; Juho Lim; Thi Thanh Hanh Nguyen; Il-Kyoon Mok; Meizi Piao; Doman Kim
Journal:  Food Sci Biotechnol       Date:  2019-11-27       Impact factor: 2.391

2.  Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically-based pharmacokinetic modelling approach.

Authors:  Jeffry Adiwidjaja; Alan V Boddy; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2020-05-13       Impact factor: 4.335

3.  Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells.

Authors:  Xinxin Ci; Rong Ren; Kan Xu; Hongyu Li; Qinlei Yu; Yu Song; Dacheng Wang; Rongtao Li; Xuming Deng
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

4.  Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis.

Authors:  Lizhi Chen; Yunyun Yang; Xuebin Wang; Chenyu Wang; Weiwei Lin; Zheng Jiao; Zhuo Wang
Journal:  Pharmgenomics Pers Med       Date:  2021-09-03

5.  Targeted Metabolomics of Serum Acylcarnitines Evaluates Hepatoprotective Effect of Wuzhi Tablet (Schisandra sphenanthera Extract) against Acute Acetaminophen Toxicity.

Authors:  Huichang Bi; Fei Li; Kristopher W Krausz; Aijuan Qu; Caroline H Johnson; Frank J Gonzalez
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-04       Impact factor: 2.629

6.  Antiproliferative activity of plant extracts used against cancer in traditional medicine.

Authors:  Wamidh H Talib; Adel M Mahasneh
Journal:  Sci Pharm       Date:  2010-02-13

7.  The Protecting Effect of Deoxyschisandrin and Schisandrin B on HaCaT Cells against UVB-Induced Damage.

Authors:  Wei Hou; Wei Gao; Datao Wang; Qingxiu Liu; Siwen Zheng; Yingping Wang
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

8.  Preparative separation and purification of deoxyschizandrin from Schisandrae Sphenantherae Fructus by high-speed counter-current chromatography.

Authors:  Xin-Ying Li; Mei Yang; Jie-Yun Huang; Xiao-Xue Yu; Min-Qian Zhao; Zhi-Kun Liang; Zhi-Sheng Xie; Xin-Jun Xu
Journal:  J Pharm Anal       Date:  2013-07-24

9.  Differential Action between Schisandrin A and Schisandrin B in Eliciting an Anti-Inflammatory Action: The Depletion of Reduced Glutathione and the Induction of an Antioxidant Response.

Authors:  Pou Kuan Leong; Hoi Shan Wong; Jihang Chen; Wing Man Chan; Hoi Yan Leung; Kam Ming Ko
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

10.  Schisandrin A suppresses lipopolysaccharide-induced inflammation and oxidative stress in RAW 264.7 macrophages by suppressing the NF-κB, MAPKs and PI3K/Akt pathways and activating Nrf2/HO-1 signaling.

Authors:  Da Hye Kwon; Hee-Jae Cha; Eun Ok Choi; Sun-Hee Leem; Gi-Young Kim; Sung-Kwon Moon; Young-Chae Chang; Seok-Joong Yun; Hye Jin Hwang; Byung Woo Kim; Wun-Jae Kim; Yung Hyun Choi
Journal:  Int J Mol Med       Date:  2017-10-25       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.